Nick Wold
About Nick Wold
Nick Wold is a biostatistician at Boston Scientific with extensive experience in clinical research and data analysis.
Current Position at Boston Scientific
Since 2008, Nick Wold has been working as a Biostatistician at Boston Scientific in the Greater Minneapolis-St. Paul Area. In his role, he interacts with regulatory bodies worldwide, including FDA, BSI, and European competent authorities. His responsibilities involve designing both pre-market and post-market CRM studies, contributing to the company's global regulatory submissions.
Past Role at University of Minnesota
Nick Wold held the position of National Research Service Award Fellow at the University of Minnesota's Coordinating Center for Biometrics Research from 2006 to 2008. In this role, he gained valuable experience in coordinating biometric research efforts in the Greater Minneapolis-St. Paul Area.
Previous Experience at Medtronic
Nick Wold worked at Medtronic in various capacities between 2004 and 2006. He started as a Clinical Studies Coordinator from 2004 to 2005 and subsequently advanced to the role of Clinical Research Associate, serving from 2005 to 2006. During his tenure at Medtronic, Wold accumulated substantial experience in clinical research operations.
Educational Background in Biostatistics
Nick Wold pursued his MS in Biostatistics at the University of Minnesota-Twin Cities from 2006 to 2008. This advanced degree equipped him with the necessary skills and knowledge for his subsequent roles in biostatistics and clinical research.
Undergraduate Studies in Mathematics
Nick Wold attended St. Olaf College from 1999 to 2003, where he earned a BA in Mathematics. This foundational education provided a strong mathematical background, pivotal for his future academic and professional pursuits in biostatistics.
Technical Skills in Data Analysis
In his role as a biostatistician, Nick Wold utilizes tools such as SAS and R for data analysis and coding. These technical skills enable him to manage and analyze complex data sets effectively, supporting his work in regulatory submissions and clinical studies design.